Ruth Alon

HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel.

Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY.

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel.

APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel.

Israel Advanced Technology Industries is an umbrella organization that represents the high-tech, life science, and other advanced technology industries. The private company is based in Hertzliya Pituach, Israel. The Israeli company was founded by Nechemia Jacob Peres, Aaron Mankovski, and Ruth Alon. The CEO is Karin Meir Rubinstein.

CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel.

330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY.

Part of Technion-Israel Institute of Technology, BioRap Technologies Ltd. is an Israeli bio-pharmaceutical company that engages in research, development, and commercialization of drugs. The private company is based in Haifa, Israel.

Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL.

Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom.

Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore.

BlueTree Technologies Ltd. is a foodtech company based in Kiryat Shmona, Israel. BlueTree's proprietary technology and system physically and selectively reduces sugar content (up to 50%%) from 100%% squeezed natural orange juice, making it natural, healthy, and tasty. The Israeli company's technology and system offer several significant benefits to the natural juice industry, including reduced sugar, improved blending properties, and improved reduced storage and distribution. BlueTree is the first "graduate" of the FreshStart Food Tech Incubator, partnered by Tnuva, Tempo, OurCrowd, and Finistere Ventures, and is one of the leading players in the thriving northern food tech ecosystem. The company was founded by Yuval Klein and Didier Toubia, and Michael Gordon has been the CEO of the company since 2022.